Gao, Y., Chen, M., Chu, Y., Yang, L., Yu, D., Liu, Y., & Hung, M. (2021). Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells. Am J Cancer Res.
Čikaški stil citiranjaGao, Yuan, Mei-Kuang Chen, Yu-Yi Chu, Liuqing Yang, Dihua Yu, Yingbin Liu, i Mien-Chie Hung. "Nuclear Translocation of the Receptor Tyrosine Kinase C-MET Reduces the Treatment Efficacies of Olaparib and Gemcitabine in Pancreatic Ductal Adenocarcinoma Cells." Am J Cancer Res 2021.
MLA način citiranjaGao, Yuan, et al. "Nuclear Translocation of the Receptor Tyrosine Kinase C-MET Reduces the Treatment Efficacies of Olaparib and Gemcitabine in Pancreatic Ductal Adenocarcinoma Cells." Am J Cancer Res 2021.